Latest Breaking News On - Gastrointestinal cancers symposium - Page 3 : comparemela.com

Tempus Introduces xM to Assess Minimal Residual Disease (MRD) in Patients with Colorectal Cancer (CRC) for Research Use Only

Tempus Introduces xM to Assess Minimal Residual Disease (MRD) in Patients with Colorectal Cancer (CRC) for Research Use Only
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Erin-carron
Kate-sasser
World-health-organization
Gastrointestinal-cancers
Gastrointestinal-cancers-symposium
Chief-scientific-officer
Published-july

Deciphera Pharmaceuticals (DCPH) Presents Long-Term Follow-Up Results from INTRIGUE Phase 3 Clinical Study in Second-Line GIST Patients

Deciphera Pharmaceuticals (DCPH) Presents Long-Term Follow-Up Results from INTRIGUE Phase 3 Clinical Study in Second-Line GIST Patients
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states
Melbourne
Victoria
Australia
Monash
South-australia
American
Matthewl-sherman
John-zalcberg
Deciphera-pharmaceuticals-inc
American-society-of-clinical-oncology
Nasdaq

Tempus Introduces xM to Assess Minimal Residual Disease (MRD) in Patients with Colorectal Cancer (CRC) for Research Use Only – IT Business Net

Tempus Introduces xM to Assess Minimal Residual Disease (MRD) in Patients with Colorectal Cancer (CRC) for Research Use Only – IT Business Net
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

Chicago
Illinois
United-states
Kate-sasser
World-health-organization
Gastrointestinal-cancers
Gastrointestinal-cancers-symposium
Chief-scientific-officer
Published-july